Hyperfine, Inc. (HYPR) Stock Price & Analysis

Hyperfine, Inc. (HYPR) closed at USD 0.78 on Thursday, October 15, 2026, down 2.50% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 0.8; the Oct 15, 2026 session ranged USD 0.76–0.81 on volume of 949,200 shares. Market capitalization is $82.73M, with a 52-week range of USD 0.75–1.94 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:20 UTC.

Also available as compact Markdown for AI agents: nexqual.com/HYPR.md

Key facts (HYPR)

Analysts (HYPR)

Consensus Buy (mean 2.00 on a 1–5 scale), 3 analysts; mean target USD 2.03 (low 1.6, high 2.5).

Rating changes, last 120 days:

DateFirmActionRatingPrice target
2026-09-22BTIGReiteratedBuy$2
2026-09-14BTIGReiteratedBuy$2
2026-08-10B. Riley SecuritiesTarget loweredBuy$2 → $1.6

Total return (dividends reinvested) (HYPR)

1Y (from 2025-10-16)5Y (from 2021-10-11)
Total return-45.1%-92.2%
S&P 500 (SPY)+18.1%+85.1%
Per year-45.2%-39.8%
Volatility (annualized)70.4%85.5%
Max drawdown-58.7% (May 2026→Sep 2026)-94.5% (Oct 2021→May 2025)

Key Statistics (as of October 16, 2026 at 05:20 UTC)

PriceUSD 0.78
Change▼ 2.50% (down)
Previous CloseUSD 0.8
OpenUSD 0.8
Day RangeUSD 0.76 – 0.81
52-Week RangeUSD 0.75 – 1.94
Volume949,200 shares
Market Cap$82.73M
ExchangeNGM

Technical Analysis (HYPR)

Nexqual's technical model rates HYPR "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:20 UTC.

Overall SignalSELL
RSI (14)40.43 (neutral)
vs SMA50Below (USD 0.85)
MACD-0 (negative)

Analyst Ratings (HYPR)

Wall Street analysts rate HYPR "Buy" based on 3 analysts, with a mean price target of USD 2.03 (range USD 1.6–2.5), per Nexqual as of October 16, 2026 at 05:20 UTC.

Consensus RatingBuy
Analyst Count3
Mean TargetUSD 2.03
High TargetUSD 2.5
Low TargetUSD 1.6
Buy / Hold / Sell3 / 0 / 0

Earnings (HYPR)

Next Earnings Date2026-11-09
EPS EstimateUSD -0.08
Revenue Estimate$5.80M

Recent Earnings History

QuarterActual vs Estimate
2026-06-30USD -0.09 vs est -0.09 ▲ beat
2025-12-31USD -0.08 vs est -0.08 ▲ beat
2025-09-30USD -0.14 vs est -0.11 ▼ miss

Source: Nexqual, October 16, 2026 at 05:20 UTC.

Financials & Fundamentals (HYPR)

Total Revenue$16.54M
Revenue Growth (latest quarter, YoY)+44.80%
Gross Margin+51.41%
Operating Margin-216.93%
Profit Margin-210.75%
ROE-96.97%
Debt / Equity0.36
Current Ratio6.15
Total Cash$43.46M
Total Debt$13.41M

Source: Nexqual, October 16, 2026 at 05:20 UTC.

Financial Health Score (HYPR)

Nexqual rates Hyperfine, Inc.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:20 UTC.

GrowthSolid — Revenue +5% YoY (annual)
ProfitabilityCritical — Heavily loss-making — early-stage company
Balance SheetStrong — $43M cash vs $13M debt, net cash position
Cash FlowWeak — Operating cash flow -$27M (TTM)
EfficiencyCritical — ROE -97%, ROA -38.8%

Ownership (HYPR)

Insider Ownership+4.44%
Institutional Ownership+22.48%
Shares Outstanding90.99M
Float86.42M
Short % of Float+4.40%

Source: Nexqual, October 16, 2026 at 05:20 UTC.

Leadership (HYPR)

Hyperfine, Inc. is led by Maria Degois-Sainz (age 59), CEO, President & Director, per Nexqual as of October 16, 2026 at 05:20 UTC.

CEO, President & DirectorMaria Degois-Sainz (age 59)
Founder & Vice ChairmanJonathan M. Rothberg (age 61)
Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate SecretaryBrett Hale (age 51)
Chief Operating OfficerThomas Teisseyre (age 41)
Vice President of TechnologyRafael O'Halloran

Major Backers & Investors (HYPR)

Notable institutional backers of Hyperfine, Inc. include Fosun International Ltd, Fidelity, Catalio Capital Management, LP , according to Nexqual as of October 16, 2026 at 05:20 UTC.

Active Investors

InvestorStake
Fosun International Ltd1.91%
Fidelity1.55%
Catalio Capital Management, LP 1.45%
Renaissance Technologies1.04%
Alphabet Inc.0.99%

Index Funds (Passive)

FundStake
BlackRock8.07%
Vanguard Group7.93%
Geode Capital2.15%
State Street1.12%
Northern Trust0.7%

Source: Nexqual, October 16, 2026 at 05:20 UTC.

Peers & Related Stocks

SymbolNamePriceChange
ESTAEstablishment Labs Holdings IncUSD 61.36▲ 4.98%
ALMRAlamar Biosciences, Inc.USD 27.42▲ 16.58%
INSPInspire Medical Systems, Inc.USD 70.12▲ 1.83%
BFLYButterfly Network, Inc.USD 7.85▼ 3.09%
AXGNAxoGen, Inc.USD 35.63▼ 1.49%
UFPTUFP Technologies, Inc.USD 297.19▲ 0.99%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:20 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt